| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Tandem Diabetes Care, Inc.'s insiders have reduced their positions by a net 1,700 shares worth roughly $33K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 160.3K | $2.83M | - | |
| VP | 52.8K | $931.7K | - | |
| CFO | 52.0K | $918.5K | - | |
| VP | 40.3K | $711.6K | - | |
| VP | 32.1K | $567.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | Kim D Blickenstaff61 | Director | Sell | 108,198 | $87.99 | $9,520,519.90 | -14.2% | |
| Dec 11, 2020 | Kim D Blickenstaff61 | Director | Sell | 9,150 | $93.00 | $850,950.00 | -1.2% | |
| Dec 9, 2020 | Kim D Blickenstaff61 | Director | Sell | 15,850 | $94.91 | $1,504,307.36 | -2.0% | |
| Dec 1, 2020 | Rebecca B Robertson73 | Director | Sale+OE | 1,500 | $94.03 | $141,040.20 | - | |
| Dec 1, 2020 | Kim D Blickenstaff61 | Director | Sell | 25,000 | $97.01 | $2,425,162.50 | -2.9% | |
| Nov 12, 2020 | Kim D Blickenstaff61 | Director | Sell | 16,802 | $106.88 | $1,795,829.08 | -1.9% | |
| Nov 10, 2020 | Kim D Blickenstaff61 | Director | Sale+OE | 25,000 | $100.09 | $2,502,272.50 | -2.8% | |
| Nov 9, 2020 | Dick Allen69 | Director | Sale+OE | 20,432 | $107.65 | $2,199,425.98 | -40.5% | |
| Oct 13, 2020 | Leigh Vosseller76 | EVP & Chief Financial Officer | Sale+OE | 10,000 | $120.87 | $1,208,728.26 | -68.9% | |
| Oct 13, 2020 | John F Sheridan55 | President & CEO | Sale+OE | 15,000 | $121.31 | $1,819,657.82 | -80.0% |